Division
The majority voted in favour of a [motion](https://www.openaustralia.org.au/senate/?gid=2023-03-09.12.1) to agree with the bill's main idea. In other words, they voted to read it for a [second time](https://peo.gov.au/understand-our-parliament/how-parliament-works/bills-and-laws/making-a-law-in-the-australian-parliament/). They can now discuss it in greater detail. ### What is the bill's main idea? According to the [bills digest](https://www.aph.gov.au/Parliamentary_Business/Bills_Legislation/bd/bd2223a/23bd046): > *The Bill proposes amendments to the Therapeutic Goods Act 1989 (the Act) that include:* > > * *imposing a new reporting requirement on CEOs of healthcare facilities for adverse events involving medical devices* > * *establishing a new ‘export only’ pathway for biologicals* > * *expanding the Therapeutic Goods Administration’s information gathering powers* > * *enabling the withdrawal of restricted advertising approval for therapeutic goods if concerns arise following the release of new efficacy information* > * *expanding the list of exempt persons who may receive direct therapeutic goods advertising and for whom the Act’s advertising requirements do not apply* > * *expanding existing powers to enable the importation or supply of (unapproved) substitutable medicines in the event of a medicine shortage where no appropriate alternative is available in the Australian Register of Therapeutic Goods and it is in the interests of public health.* > > *Several of these amendments build on ongoing therapeutic goods reforms and are in response to stakeholder feedback.*
Senate, 2023-03-09. affirmative: ayes 35, noes 3.
Question
The majority voted in favour of a [motion](https://www.openaustralia.org.au/senate/?gid=2023-03-09.12.1) to agree with the bill's main idea. In other words, they voted to read it for a [second time](https://peo.gov.au/understand-our-parliament/how-parliament-works/bills-and-laws/making-a-law-in-the-australian-parliament/). They can now discuss it in greater detail. ### What is the bill's main idea? According to the [bills digest](https://www.aph.gov.au/Parliamentary_Business/Bills_Legislation/bd/bd2223a/23bd046): > *The Bill proposes amendments to the Therapeutic Goods Act 1989 (the Act) that include:* > > * *imposing a new reporting requirement on CEOs of healthcare facilities for adverse events involving medical devices* > * *establishing a new ‘export only’ pathway for biologicals* > * *expanding the Therapeutic Goods Administration’s information gathering powers* > * *enabling the withdrawal of restricted advertising approval for therapeutic goods if concerns arise following the release of new efficacy information* > * *expanding the list of exempt persons who may receive direct therapeutic goods advertising and for whom the Act’s advertising requirements do not apply* > * *expanding existing powers to enable the importation or supply of (unapproved) substitutable medicines in the event of a medicine shortage where no appropriate alternative is available in the Australian Register of Therapeutic Goods and it is in the interests of public health.* > > *Several of these amendments build on ongoing therapeutic goods reforms and are in response to stakeholder feedback.*
How each member voted
Per-member votes are not present in this static export. Consult the original division record.
Related bills
Only formal divisions leave a per-member record. A procedural vote is not necessarily a vote for or against a bill.